Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Hedley

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Advances in Cancer Research|July 15, 2009
Tumor dormancy and metastasisBenjamin D Hedley, Ann F Chambers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
The role of erythropoietin and erythropoiesis-stimulating agents in tumor progressionBenjamin D Hedley, Alison L Allan, Anargyros Xenocostas
Expert Opinion on Therapeutic Targets|December 9, 2004
Therapeutic targets for antimetastatic therapyBenjamin D Hedley, Eric Winquist, Ann F Chambers
Future Oncology (London, England)|October 10, 2006
Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growthBenjamin D Hedley, Alison L Allan, Ann F Chambers
Cytometry. Part B, Clinical Cytometry|May 7, 2015
Novel lymphocyte screening tube using dried monoclonal antibody reagentsBenjamin D Hedley, Michael Keeney, Janice Popma, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 18, 2012
User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® systemLori E Lowes, Benjamin D Hedley, Mike Keeney, et al.
Journal of Visualized Experiments : Jove|March 19, 2014
Adaptation of semiautomated circulating tumor cell (CTC) assays for clinical and preclinical research applicationsLori E Lowes, Benjamin D Hedley, Michael Keeney, et al.
Cytometry. Part B, Clinical Cytometry|October 3, 2020
Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelinesLori E Lowes, Benjamin D Hedley, D Robert Sutherland, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 22, 2013
Response to Rossi et alLori E Lowes, Benjamin D Hedley, Mike Keeney, et al.
Current Protocols|March 9, 2022
Measurable Residual Disease Detection in B-Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) MethodMichael J Borowitz, Brent L Wood, Michael Keeney, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Advances in Cancer Research|July 15, 2009
Tumor dormancy and metastasisBenjamin D Hedley, Ann F Chambers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
The role of erythropoietin and erythropoiesis-stimulating agents in tumor progressionBenjamin D Hedley, Alison L Allan, Anargyros Xenocostas
Expert Opinion on Therapeutic Targets|December 9, 2004
Therapeutic targets for antimetastatic therapyBenjamin D Hedley, Eric Winquist, Ann F Chambers
Future Oncology (London, England)|October 10, 2006
Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growthBenjamin D Hedley, Alison L Allan, Ann F Chambers
Cytometry. Part B, Clinical Cytometry|May 7, 2015
Novel lymphocyte screening tube using dried monoclonal antibody reagentsBenjamin D Hedley, Michael Keeney, Janice Popma, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 18, 2012
User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® systemLori E Lowes, Benjamin D Hedley, Mike Keeney, et al.
Journal of Visualized Experiments : Jove|March 19, 2014
Adaptation of semiautomated circulating tumor cell (CTC) assays for clinical and preclinical research applicationsLori E Lowes, Benjamin D Hedley, Michael Keeney, et al.
Cytometry. Part B, Clinical Cytometry|October 3, 2020
Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelinesLori E Lowes, Benjamin D Hedley, D Robert Sutherland, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 22, 2013
Response to Rossi et alLori E Lowes, Benjamin D Hedley, Mike Keeney, et al.
Current Protocols|March 9, 2022
Measurable Residual Disease Detection in B-Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) MethodMichael J Borowitz, Brent L Wood, Michael Keeney, et al.
Pageof 4